SCHEMBL6356455

SCHEMBL6356455

COc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.58
MAPT P10636 4/20 0.53
TP53 P04637 2/20 0.51
NPC1 O15118 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
ALB P02768 1/20 0.48
KMT2A Q03164 3/20 0.47
LMNA P02545 4/20 0.46
TSHR P16473 4/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
ALOX15 P16050 1/20 0.46
MEN1 O00255 2/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353827 0.91 ALB (0.52) MAPTTP53ALBKMT2ALMNA
SCHEMBL6352341 0.90 TP53 (0.54) HSD17B10MAPTTP53NPC1RAB9A
SCHEMBL6352316 0.85 ALB (0.67) TP53ALBLMNASMN1; SMN2PPARG
SCHEMBL6351095 0.84 MAPT (0.53) HSD17B10MAPTTP53NPC1CASP3
SCHEMBL6834058 0.82 MAPT (0.49) HSD17B10MAPTTP53ALBKMT2A
SCHEMBL6833566 0.82 MAPT (0.51) MAPTALBKMT2ALMNAMEN1
SCHEMBL6830625 0.81 MAPT (0.48) HSD17B10MAPTTP53ALBKMT2A
SCHEMBL6357053 0.80 ALB (0.51) HSD17B10MAPTALBKMT2ALMNA
SCHEMBL6358680 0.80 ALB (0.52) HSD17B10MAPTALBKMT2ALMNA
SCHEMBL6346681 0.74 KMT2A (0.61) MAPTTP53KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 HSD17B10 2585/4885MAPT 4753/4885TP53 2308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.